类药物对肝脏的影响:祸害还是福利?
George Zacharia1, Anu Jacob2, Manivarnan Karichery3
1Medical Gastroenterology, Ahalia Hospital, Abu Dhabi, UAE.
Canadian liver journal
|July 18, 2025
概括
通过抑制胆固醇合成,他类药物对于管理高胆固醇和心血管疾病至关重要. 尽管存在罕见的肝损伤风险,但大量证据证实了他类药物的存在.
科学领域:
- 药理学和治疗学 药理学和治疗学
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 类药物是高胆固醇血症和动脉样硬化心血管疾病的首要治疗方法.
- 它们通过抑制HMG-CoA减少酶来起作用,这是胆固醇生物合成中的关键酶.
- 类药物除了减少脂质之外,还具有有益的类作用,包括抗炎和抗氧化特性.
研究的目的:
- 提供关于他类药物的全面审查.
- 阐明它们的作用机制和类效应.
- 解决关于他类药物诱导性肝损伤 (SILI) 的担忧,并探索它们在肝脏疾病中的治疗潜力.
主要方法:
- 关于他类药物的机制,安全性和有效性的科学证据的文献综述.
- 对与他类药物相关的肝脏不良事件发生率和类型的数据的分析.
- 评估关于他类药物在治疗肝脏相关疾病中的作用的研究.
主要成果:
- 类他类药物有效降低胆固醇,并具有多益性益处.
- 类药物诱导的肝损伤 (SILI) 是罕见的,发病率低于1%.
- 观察到的肝脏不良反应通常是轻微和可逆的;严重的结果是非常罕见的.
结论:
- 证据压倒性地支持他类药物的安全性和益处.
- 关于广泛使用他类药物的肝毒性方面的担忧基本上是毫无根据的.
- 类药物在治疗诸如非酒精性脂肪肝病等疾病方面具有治疗价值.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
878
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
878
Hepatic Drug Excretion: Influencing Factors
227
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
227
Cholesterol: Significance and Regulation
694
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
694
Hepatic Drug Clearance: Effect of Protein Binding
286
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
286
Atherosclerosis III: Management
36
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
36
Liver Physiology
1.3K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.3K


